Medical Oncology

Inflammatory Bowel Disease

Questions discussed in this category

In patients with active IBD and rectal cancer, do you take any precautions before starting TNT?

Would you wait until bowel symptoms are controlled or ever pursue diversion before starting treatment?

How would you treat a patient with metastatic renal cell cancer with Crohn's disease after failing available tyrosine kinase inhibitor therapies?

Is Crohn's diagnosis an absolute contraindication for immunotherapy?

3 Answers available

Is it necessary to hold immunotherapy during a 4-6wk steroid taper after resolution of immunotherapy related toxicity?

Would you ever considering re-starting immunotherapy before completing the taper? According to the new guildelines on managing immunotherapy related ...

1 Answer available

Papers discussed in this category

The New England journal of medicine, 2013-08-22

Vedolizumab as induction and maintenance therapy for Crohn's disease.

JAMA oncology, 2016-02

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

Annals of oncology : official journal of the European Society for Medical Oncology, 2017-02-01

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab.

Ann Oncol,

Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Immunology,

Integrin signalling and function in immune cells.

J Immunother Cancer, 2019 Jan 06

Complete response of metastatic melanoma in a patient with Crohn's disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies.

Medical Oncology

Inflammatory Bowel Disease

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology